- Home
- BNTX vs GH Comparison
BNTX vs GH Comparison
Compare BNTX & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | GH |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 21.6B |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BNTX | GH |
|---|---|---|
| Price | $91.71 | $155.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 19 |
| Target Price | ★ $133.46 | $119.79 |
| AVG Volume (30 Days) | 780.9K | ★ 2.8M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $982,021,000.00 |
| Revenue This Year | N/A | $33.30 |
| Revenue Next Year | $3.37 | $28.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.88 |
| 52 Week Low | $79.81 | $40.36 |
| 52 Week High | $124.00 | $174.08 |
Technical Indicators
Market Signals| Indicator | BNTX | GH |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 56.96 |
| Support Level | $90.95 | $152.64 |
| Resistance Level | $94.20 | $174.08 |
| Average True Range (ATR) | 2.27 | 7.89 |
| MACD | -0.16 | -1.71 |
| Stochastic Oscillator | 32.74 | 29.00 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.